Coagulation Testing Market

Coagulation Testing Market (Product - Instruments, Consumables; Test Type: PT, APTT, TT, and ACT; End User - Hospitals and Clinics, Diagnostic Laboratories, and Home Care Settings) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Rising prevalence of geriatric population, cardiovascular diseases, and blood disorders are contributing to high adoption rate of coagulation testing. Further, high demand for point of care (POC) coagulation testing and technological advancement in the coagulation testing is adding to growth of the market.

As per market analysts, blood coagulation testing market is anticipated to grow at a lucrative rate due to development of healthcare infrastructure coupled with increased healthcare expenditure.

Meanwhile, nowadays people are involved in preventive healthcare rather than proactive healthcare. Hence, people are undergoing medical tests periodically.  This, in turn, is fuelling the demand for haemostasis analyzers.

Registering the trend, the players are also focussing on providing quality testing kits.

Moreover, rapid expansion of healthcare infrastructure in developed and emerging economies is one of the key driving factors aiding to growth of the market. Availability of advanced coagulation testing kit, with ability to conduct tests with high accuracy is another major driving factor.  

Favourable government policies favouring best healthcare delivery in several region is promoting the use of such kits.

On the other hand, high cost of such devices is likely to limit adoption rate. Further, strict regulations for approval of testing devices are restraining the growth of the market.

However, rising demand for disposable coagulation testing equipment is presenting lucrative growth opportunities in near future.

Distribution channels are playing significant role in expansion of the coagulation testing market. The kit is easily available at offline drug stores. Meanwhile, emerging e-commerce platforms is enhancing visibility of the product.

Cost-effectiveness and highly reliable kits are likely to spur the market growth in coming years.

Coagulation Testing Market: Snapshot

Blood testing measuring the blood’s ability to clot and the time taken for the same is known as coagulation testing. Clotting disorders can cause excessive bleeding or clotting and can thus be fatal in either scenario. Coagulation testing is ordered if the physician suspects clotting disorders. There are a number of bleeding disorders which are either acquired or inherited, the most common among them being hemophilia, blood factor deficiency, etc.

The global market for coagulation testing was worth US$1,730 million in 2016, and is expected to exhibit a solid 9% CAGR in the 2017-2025 forecast period to end up at a valuation of US$3,715.8 million.

Bleeding disorders can cause abnormal bleeding, therefore it is of the utmost importance to diagnose the disorders and monitor the coagulation status. The global coagulation testing market is witnessing significant growth due to growing prevalence of blood clotting disorders in many regions and the rise in cardiovascular disorders, which can also require regular coagulation testing.

coagulation testing market

PT Testing Likely to Dominate Coagulation Testing Market

The global coagulation testing market is segmented on the basis of product type into instruments and consumables. Consumables accounted for over 80% of the global coagulation testing market in 2016. The segment is anticipated to dominate the coagulation testing market throughout the forecast period. On the basis of test type, the coagulation testing market is segmented into PT, APTT, TT, ACT, and others. The PT test segment accounted for the highest share, accounting for over 70% of the coagulation testing market in 2016.

Based on end user, the global market is segmented into hospitals and clinics, diagnostic laboratories, home care settings and others. The diagnostic laboratories segment is anticipated to expand at a fast CAGR of close to 10% during the forecast period, while hospitals and clinics are likely to remain the leading contributor to the coagulation testing market.

APAC to Exhibit Rapid CAGR despite Dominance of North America, Europe

Geographically, North America and Europe are the major regions where revenue is derived from coagulation testing. The U.S., the U.K., and Germany show high adoption rates of coagulation testing instruments such as analyzers, POC testing PT monitors, etc. due to rise in awareness amongst people about the importance of detecting and monitoring their coagulation status, high prevalence of cardiovascular diseases, and the availability of a favorable reimbursement scenario. The coagulation testing market is likely to be valued at more than US$1 bn in both North America and Europe by 2025, with the two being valued at US$678.2 mn and US$569.2 mn in 2016, respectively.

The coagulation testing market in Asia Pacific is said to be at a primary stage. It is anticipated that Asia Pacific will gain significant market share over the forecast period. Some of the key driving forces for coagulation testing market in emerging countries in the region are rising awareness, increasing population, entry of new players focusing on emerging markets, and increase in healthcare funding. The Asia Pacific market for coagulation testing is expected to exhibit a robust 10.8% CAGR over the 2017-2025 forecast period, rising from a 2016 valuation of US$358.1 mn to US$891.8 mn by 2025.

Some of the key players in the global coagulation testing market are Alere Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers, SYSMEX CORPORATION, Universal Biosensors, Inc., HemoSonics, LLC, and Helena Laboratories, Inc. Testing with high specificity and accuracy is likely to remain a major factor in the global coagulation testing market.

Global Coagulation Testing market is segmented as below:

By Product Type

  • Instruments
  • Consumables

By Test Type

  • PT
  • APTT
  • TT
  • ACT
  • Others

By End Users

  • Hospitals and Clinics
  • Diagnostics Laboratories
  • Home Care Settings
  • Others

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

    1. Preface
         1.1. Market Definition and Scope
         1.2. Market Segmentation
         1.3. Key Research Objectives
         1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Coagulation Testing Market

    4. Market Overview
         4.1. Introduction
                 4.1.1. Product Definition
         4.2. Market Dynamics
                 4.2.1. Drivers
                            4.2.1.1. Economic Drivers
                            4.2.1.2. Supply Side Drivers
                            4.2.1.3. Demand Side Drivers
                 4.2.2. Restraints
                 4.2.3. Opportunities
                 4.2.4. Key Trends

    5. Global Coagulation Testing Market Analysis and Forecast, 2017-2025
         5.1. Market Revenue Projections (US$ Mn)
         5.2. Porter’s Five forces Analysis: Global Coagulation Testing Market
         5.3. Recent Development (Industry Updates, Merger & Acquisition) 
         5.4. Types of Blood Clotting Disorders
         5.5. Coagulation Pathways
         5.6. Future Market Outlook

    6. Global Coagulation Testing Market Analysis and Forecast, By Product Type
         6.1. Introduction & Definition
         6.2. Key Findings / Developments
         6.3. Market Value (US$ Mn) Forecast By Product Type
                 6.3.1. Instruments
                 6.3.2. Consumables
         6.4. Market Attractiveness By Product Type

    7. Global Coagulation Testing Market Analysis and Forecast, By Test Type
         7.1. Introduction & Definition
         7.2. Key Findings / Developments
         7.3. Market Value (US$ Mn) Forecast By Test Type
                 7.3.1. PT
                 7.3.2. APTT
                 7.3.3. TT
                 7.3.4. ACT
                 7.3.5. Others 
         7.4. Market Attractiveness By Test Type

    8. Global Coagulation Testing Market Analysis and Forecast, By End User
         8.1. Introduction & Definition
         8.2. Key Findings / Developments
         8.3. Market Value (US$ Mn) Forecast By End User
                 8.3.1. Hospitals and Clinics
                 8.3.2. Diagnostic Laboratories
                 8.3.3. Home Care Settings
                 8.3.4. Others 
         8.4. Market Attractiveness By End User

    9. Global Coagulation Testing Market Analysis and Forecasts, By Region
         9.1. Key Findings
         9.2. Market Value (US$ Mn) Forecast By Region
                 9.2.1. North America
                 9.2.2. Europe
                 9.2.3. Asia Pacific
                 9.2.4. Latin America
                 9.2.5. Middle East and Africa
         9.3. Market Attractiveness By Region

    10. North America Coagulation Testing Market Analysis and Forecast
         10.1. Key Findings
         10.2. Market Value (US$ Mn) Forecast By Product Type
                 10.2.1. Instruments
                 10.2.2. Consumables
         10.3. Market Value (US$ Mn) Forecast By Test Type
                 10.3.1. PT
                 10.3.2. APTT
                 10.3.3. TT
                 10.3.4. ACT
                 10.3.5. Others 
         10.4. Market Value (US$ Mn) Forecast By End User
                 10.4.1. Hospitals and Clinics
                 10.4.2. Private Diagnostic Laboratories
                 10.4.3. Home Care Settings
                 10.4.4. Others 
         10.5. Market Value (US$ Mn) Forecast By Country
                 10.5.1. U.S.
                 10.5.2. Canada
         10.6. Market Attractiveness Analysis 
                 10.6.1. By Product Type
                 10.6.2. By Test Type
                 10.6.3. By End User
                 10.6.4. By Country

    11.  Europe Coagulation Testing Market Analysis and Forecast
         11.1. Key Findings
         11.2. Market Value (US$ Mn) Forecast By Product Type
                 11.2.1. Instruments
                 11.2.2. Consumables
         11.3. Market Value (US$ Mn) Forecast By Test Type
                 11.3.1. PT
                 11.3.2. APTT
                 11.3.3. TT
                 11.3.4. ACT
                 11.3.5. Others 
         11.4. Market Value (US$ Mn) Forecast By End User
                 11.4.1. Hospitals and Clinics
                 11.4.2. Diagnostic Laboratories
                 11.4.3. Home Care Settings
                 11.4.4. Others 
         11.5. Market Value (US$ Mn) Forecast By Country
                 11.5.1. Germany
                 11.5.2. U.K.
                 11.5.3. France
                 11.5.4. Spain
                 11.5.5. Italy
                 11.5.6. Rest of Europe
         11.6. Market Attractiveness Analysis 
                 11.6.1. By Product Type
                 11.6.2. By Test Type
                 11.6.3. By End User
                 11.6.4. By Country

    12. Asia Pacific Coagulation Testing Market Analysis and Forecast
         12.1. Key Findings
         12.2. Market Value (US$ Mn) Forecast By Product Type
                 12.2.1. Instruments
                 12.2.2. Consumables
         12.3. Market Value (US$ Mn) Forecast By Test Type
                 12.3.1. PT
                 12.3.2. APTT
                 12.3.3. TT
                 12.3.4. ACT
                 12.3.5. Others 
         12.4. Market Value (US$ Mn) Forecast By End User
                 12.4.1. Hospitals and Clinics
                 12.4.2. Diagnostic Laboratories
                 12.4.3. Home Care Settings
                 12.4.4. Others 
         12.5. Market Value (US$ Mn) Forecast By Country
                 12.5.1. China
                 12.5.2. Japan
                 12.5.3. India
                 12.5.4. Australia & New Zealand
                 12.5.5. Rest of Asia Pacific
         12.6. Market Attractiveness Analysis 
                 12.6.1. By Product Type
                 12.6.2. By Test Type
                 12.6.3. By End User
                 12.6.4. By Country

    13. Latin America Coagulation Testing Market Analysis and Forecast
         13.1. Key Findings
         13.2. Market Value (US$ Mn) Forecast By Product Type
                 13.2.1. Instrument
                 13.2.2. Consumables
         13.3. Market Value (US$ Mn) Forecast By Test Type
                 13.3.1. PT
                 13.3.2. APTT
                 13.3.3. TT
                 13.3.4. ACT
                 13.3.5. Others 
         13.4. Market Value (US$ Mn) Forecast By End User
                 13.4.1. Hospitals and Clinics
                 13.4.2. Diagnostic Laboratories
                 13.4.3. Home Care Settings
                 13.4.4. Others 
         13.5. Market Value (US$ Mn) Forecast By Country
                 13.5.1. Brazil
                 13.5.2. Mexico
                 13.5.3. Rest of Latin America
         13.6. Market Attractiveness Analysis 
                 13.6.1. By Product Type
                 13.6.2. By Test Type
                 13.6.3. By End User
                 13.6.4. By Country

    14. Middle East and Africa Coagulation Testing Market Analysis and Forecast
         14.1. Key Findings
         14.2. Market Value (US$ Mn) Forecast By Product Type
                 14.2.1. Instruments
                 14.2.2. Consumables
         14.3. Market Value (US$ Mn) Forecast By Test Type
                 14.3.1. PT
                 14.3.2. APTT
                 14.3.3. TT
                 14.3.4. ACT
                 14.3.5. Others 
         14.4. Market Value (US$ Mn) Forecast By End User
                 14.4.1. Hospitals and Clinics
                 14.4.2. Private Diagnostic Laboratories
                 14.4.3. Home Care Settings
                 14.4.4. Others 
         14.5. Market Value (US$ Mn) Forecast By Country
                 14.5.1. Saudi Arabia
                 14.5.2. South Africa
                 14.5.3. Rest of MEA
         14.6. Market Attractiveness Analysis 
                 14.6.1. By Product Type
                 14.6.2. By Test Type
                 14.6.3. By End User
                 14.6.4. By Country

    15.  Competition Landscape
         15.1. Market Player – Competition Matrix 
         15.2. Market Share Analysis By Company (2016)
         15.3. Company Profiles
                 15.3.1. F. Hoffmann-La Roche Ltd.
                            15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                            15.3.1.2 Product Portfolio
                            15.3.1.3 SWOT Analysis
                            15.3.1.4 Financial Overview
                            15.3.1.5 Strategic Overview
                 15.3.2. Abbott Laboratories 
                            15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                            15.3.1.2 Product Portfolio
                            15.3.1.3 SWOT Analysis
                            15.3.1.4 Financial Overview
                            15.3.1.5 Strategic Overview
                 15.3.3. Siemens Healthineers 
                            15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                            15.3.1.2 Product Portfolio
                            15.3.1.3 SWOT Analysis
                            15.3.1.4 Financial Overview
                            15.3.1.5 Strategic Overview
                 15.3.4. SYSMEX CORPORATION 
                            15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                            15.3.1.2 Product Portfolio5
                            15.3.1.3 SWOT Analysis
                            15.3.1.4 Financial Overview
                            15.3.1.5 Strategic Overview
                 15.3.5. Universal Biosensors, Inc.
                            15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                            15.3.1.2 Product Portfolio
                            15.3.1.3 SWOT Analysis
                            15.3.1.4 Financial Overview
                            15.3.1.5 Strategic Overview
                 15.3.6. HemoSonics, LLC
                            15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                            15.3.1.2 Product Portfolio
                            15.3.1.3 SWOT Analysis
                            15.3.1.4 Financial Overview
                            15.3.1.5 Strategic Overview
                 15.3.7. Thermo Fisher Scientific, Inc.
                            15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                            15.3.1.2 Product Portfolio
                            15.3.1.3 SWOT Analysis
                            15.3.1.4 Financial Overview
                            15.3.1.5 Strategic Overview
                 15.3.8. Helena Laboratories, Inc.
                            15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                            15.3.1.2 Product Portfolio
                            15.3.1.3 SWOT Analysis
                            15.3.1.4 Financial Overview
                            15.3.1.5 Strategic Overview
                 15.3.9. Alere Inc.
                            15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                            15.3.1.2 Product Portfolio
                            15.3.1.3 SWOT Analysis
                            15.3.1.4 Financial Overview
                            15.3.1.5 Strategic Overview
                 15.3.10.  Randox Laboratories Ltd.
                            15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                            15.3.1.2 Product Portfolio
                            15.3.1.3 SWOT Analysis
                            15.3.1.4 Financial Overview
                            15.3.1.5 Strategic Overview
                 15.3.11.  HORIBA, Ltd
                            15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                            15.3.1.2 Product Portfolio
                            15.3.1.3 SWOT Analysis
                            15.3.1.4 Financial Overview
                            15.3.1.5 Strategic Overview
                 15.3.12.  Agappe Diagnostics Ltd.
                            15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                            15.3.1.2 Product Portfolio
                            15.3.1.3 SWOT Analysis
                            15.3.1.4 Financial Overview
                            15.3.1.5 Strategic Overview
                 15.3.13.  Medtronic plc
                            15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                            15.3.1.2 Product Portfolio
                            15.3.1.3 SWOT Analysis
                            15.3.1.4 Financial Overview
                            15.3.1.5 Strategic Overview

    List of Tables

    Table 01: Acronyms Used
    Table 02: Global Coagulation Testing  Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
    Table 03: Global Coagulation Testing Market Value (US$ Mn) Forecast, by Test Types, 2015–2025 
    Table 04: Global Coagulation Testing Market Size (US$ Mn) Forecast, by End Users, 2015–2025
    Table 05: Global coagulation testing Market Size (US$ Mn) Forecast, by Region, 2015–2025 
    Table 06: North America Coagulation Testing Market Value (US$ Mn) Forecast, by Product Type, 2015–2025 
    Table 07: North America Coagulation Testing Market Value (US$ Mn) Forecast, by Test Types,2015–2025
    Table 08: North America Coagulation Testing Market Value (US$ Mn) Forecast, by End Users, 2015–2025
    Table 09: North America Coagulation Testing Market Value (US$ Mn) Forecast, by Country, 2015–2025
    Table 10: Europe Coagulation Testing Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
    Table 11: Europe Coagulation Testing Market Value (US$ Mn) Forecast, by Test Types,2015–2025
    Table 12: Europe Coagulation Testing Market Value (US$ Mn) Forecast, by End Users, 2015–2025
    Table 13: Europe Coagulation Testing Market Value (US$ Mn) Forecast, by Country, 2015–2025 
    Table 14: Asia Pacific Coagulation Testing Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
    Table 15: Asia Pacific Coagulation Testing Market Value (US$ Mn) Forecast, by Test Types,2015–2025
    Table 16: Asia Pacific Coagulation Testing Market Value (US$ Mn) Forecast, by End Users, 2015–2025
    Table 17: Asia Pacific Coagulation Testing Market Value (US$ Mn) Forecast, by Country, 2015–2025
    Table 18: Latin America Coagulation Testing Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
    Table 19: Latin America Coagulation Testing Market Value (US$ Mn) Forecast, by Test Types,2015–2025
    Table 20: Latin America Coagulation Testing Market Value (US$ Mn) Forecast, by End Users, 2015–2025
    Table 21: Latin America Coagulation Testing Market Value (US$ Mn) Forecast, by Country, 2015–2025
    Table 22: Middle East & Africa Coagulation Testing Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
    Table 23: Middle East & Africa Coagulation Testing Market Value (US$ Mn) Forecast, by Test Types,2015–2025
    Table 24: Middle East & Africa Coagulation Testing Market Value (US$ Mn) Forecast, by End Users, 2015–2025
    Table 25: Middle East & Africa Coagulation Testing Market Value (US$ Mn) Forecast, by Country, 2015–2025

    List of Figures

    Figure 01: Global Coagulation Testing Market By Test types, Market Size (US$ Mn), 2016 (A)
    Figure 02: Global Coagulation Testing Market Revenue (%), by End Users, 2016 (A)
    Figure 03: Distribution of Coagulation Testing Market by Region, 2016 and 2025
    Figure 04: Global Coagulation Testing Market Size (US$ Mn) Forecast, 2015–2025
    Figure 05: Porter’s Five Forces Analysis
    Figure 06: Market Value Share, by Product Type (2016)
    Figure 07: Market Value Share, by Test Types (2016)
    Figure 08: Market Value Share, by End Users(2016)
    Figure 09: Global Coagulation Testing Market Value Share Analysis, by Product Type, 2016 and 2025
    Figure 10: Global Coagulation Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Instruments, 2015–2025
    Figure 11: Global Coagulation Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Consumables, 2015–2025
    Figure 12: Global Coagulation Testing Market Attractiveness Analysis, by Product Type
    Figure 13: Global Coagulation Testing Market Value Share Analysis, by Test Types, 2016 and 2025 
    Figure 14: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), PT test, 2015–2025
    Figure 15: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by APTT Test, 2015–2025
    Figure 16: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by TT Test, 2015–2025
    Figure 17: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by ACT test, 2015–2025
    Figure 18: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
    Figure 19: Global Coagulation Testing Market Attractiveness Analysis, by Test Types
    Figure 20: Global coagulation testing Market Value Share Analysis, by End Users, 2016 and 2025
    Figure 21: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital and Clinics, 2015–2025
    Figure 22: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2015–2025
    Figure 23: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Home care settings, 2015–2025
    Figure 24: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
    Figure 25: Global coagulation testing Market Attractiveness Analysis, by End Users, 2017–2025
    Figure 26: Global Coagulation Testing Market Scenario
    Figure 27: Global coagulation testing Market Value Share Analysis, by Region, 2016 and 2025
    Figure 28: Global coagulation testing Market Attractiveness Analysis, by Region
    Figure 29: North America Coagulation Testing Market Size (US$ Mn) Forecast, 2015–2025
    Figure 30: North America Coagulation Testing Market Value Share Analysis, by Product Type, 2016 and 2025
    Figure 31: North America Coagulation Testing Market Value Share Analysis, by Test Types, 2016 and 2025
    Figure 32: North America Coagulation Testing Market Value Share Analysis, by End Users, 2016 and 2025
    Figure 33: North America Coagulation Testing Market Value Share Analysis, by Country, 2016 and 2025
    Figure 34: North America Coagulation Testing Market Attractiveness Analysis, by Product Type
    Figure 35: North America Coagulation Testing Market Attractiveness Analysis, by Test Types
    Figure 36: North America Coagulation Testing Market Attractiveness Analysis, by End Users 
    Figure 37: North America Market Attractiveness Analysis, by Country
    Figure 38: Europe Coagulation Testing Market Size (US$ Mn) Forecast, 2015–2025
    Figure 39: Europe Coagulation Testing Market Value Share Analysis, by Product Type, 2016 and 2025
    Figure 40: Europe Coagulation Testing Market Value Share Analysis, by Test Types, 2016 and 2025
    Figure 41: Europe Coagulation Testing Market Value Share Analysis, by End Users, 2016 and 2025
    Figure 42: Europe Coagulation Testing Market Value Share Analysis, by Country, 2016 and 2025
    Figure 43: Europe Coagulation Testing Market Attractiveness Analysis, by Product Type
    Figure 44: Europe Coagulation Testing Market Attractiveness Analysis, by Test Type
    Figure 45: Europe Coagulation Testing Market Attractiveness Analysis, by End Users
    Figure 46: Europe Market Attractiveness Analysis, by Country
    Figure 47: Asia Pacific Coagulation Testing Market Size (US$ Mn) Forecast, 2015–2025
    Figure 48: Asia Pacific Coagulation Testing Market Value Share Analysis, by Product Type, 2016 and 2025
    Figure 49: Asia Pacific Coagulation Testing Market Value Share Analysis, by Test Types, 2016 and 2025
    Figure 50: Asia Pacific Coagulation Testing Market Value Share Analysis, by End Users, 2016 and 2025
    Figure 51: Asia Pacific Coagulation Testing Market Value Share Analysis, by Country, 2016 and 2025
    Figure 52: Asia Pacific Coagulation Testing Market Attractiveness Analysis, by Product Type
    Figure 53: Asia Pacific Coagulation Testing Market Attractiveness Analysis, by Test Types
    Figure 54: Asia Pacific Coagulation Testing Market Attractiveness Analysis, by End Users 
    Figure 55: Asia Pacific Market Attractiveness Analysis, by Country
    Figure 56: Latin America Coagulation Testing Market Size (US$ Mn) Forecast, 2017–2025eval
    Figure 57: Latin America Coagulation Testing Market Value Share Analysis, by Product Type, 2016 and 2025
    Figure 58: Latin America Coagulation Testing Market Value Share Analysis, by Test Types, 2016 and 2025
    Figure 59: Latin America Coagulation Testing Market Value Share Analysis, by End Users, 2016 and 2025
    Figure 60: Latin America Coagulation Testing Market Value Share Analysis, by Country, 2016 and 2025
    Figure 61: Latin America Coagulation Testing Market Attractiveness Analysis, by Product Type
    Figure 62: Latin America Coagulation Testing Market Attractiveness Analysis, by Test Types
    Figure 63: Latin America Coagulation Testing Market Attractiveness Analysis, by End Users 
    Figure 64: Latin America Market Attractiveness Analysis, by Country
    Figure 65: Middle East & Africa Coagulation Testing Market Size (US$ Mn) Forecast, 2015–2025
    Figure 66: Middle East & Africa Coagulation Testing Market Value Share Analysis, by Product Type, 2016 and 2025
    Figure 67: Middle East & Africa Coagulation Testing Market Value Share Analysis, by Test Types, 2016 and 2025
    Figure 68: Middle East & Africa Coagulation Testing Market Value Share Analysis, by End Users, 2016 and 2025
    Figure 69: Middle East & Africa Coagulation Testing Market Value Share Analysis, by Country, 2016 and 2025
    Figure 70: Middle East & Africa Coagulation Testing Market Attractiveness Analysis, by Product Type
    Figure 71: Middle East & Africa Coagulation Testing Market Attractiveness Analysis, by Test Types
    Figure 72: Middle East & Africa Coagulation Testing Market Attractiveness Analysis, by End Users
    Figure 73: Middle East & Africa Market Attractiveness Analysis, by Country
    Figure 74: Global Coagulation Testing Market Share Analysis, by Company (2016)
    Figure 75: Breakdown of Net Sales, by Segment, 2016,(F. Hoffmann-La Roche)
    Figure 76: Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016, ,(F. Hoffmann-La Roche)

Copyright © Transparency Market Research, Inc. All Rights reserved